Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Ting-ting Feng"'
Publikováno v:
Linchuang shenzangbing zazhi, Vol 24, Iss 10, Pp 827-833 (2024)
Objective To observe the effects of nutritional support on nutritional status and calcium and phosphorus metabolism in maintenance hemodialysis （MHD） patients. Methods From June 2023 to August 2023， patients with end-stage renal disease （ESRD
Externí odkaz:
https://doaj.org/article/2fe436970fe8423f81e1ccd654c99213
Publikováno v:
International Journal of Ophthalmology, Vol 17, Iss 4, Pp 676-685 (2024)
AIM: To identify different metabolites, proteins and related pathways to elucidate the causes of proliferative diabetic retinopathy (PDR) and resistance to anti-vascular endothelial growth factor (VEGF) drugs, and to provide biomarkers for the diagno
Externí odkaz:
https://doaj.org/article/429fcdeb55284c9485badfa9c4dd1733
Autor:
Da Song, Jia-Jun Liang, Shi-Biao Pu, Pan-Pan Zhang, Yun-Lin Peng, Xia Liu, Ting-Ting Feng, Xiang Pu, Ying Zhou, Xiong-Wei Liu, Xin Wei
Publikováno v:
Molecules, Vol 28, Iss 6, p 2531 (2023)
Two new monoterpenoid indole alkaloids, gelselegandines F (1) and G (2), were isolated from the aerial parts of Gelsemium elegans. Their structures were elucidated by means of spectroscopic techniques and quantum chemical calculations. The ECD calcul
Externí odkaz:
https://doaj.org/article/92eca4969e564c3aa3786a268a52c668
Autor:
Ting-Ting Feng, Jing-Xian Zhang, Yong-Peng Zhang, Jian Sun, Hong Yu, Xiang Tao, Xiu-Hong Mao, Qing Hu, Shen Ji
Publikováno v:
Molecules, Vol 27, Iss 9, p 2651 (2022)
Quality control of animal-derived traditional Chinese medicines has improved dramatically as proteomics research advanced in the past few decades. However, it remains challenging to identify quality attributes with routine proteomics approaches since
Externí odkaz:
https://doaj.org/article/81504a7d8ad340e68a476aa188d0f586
Autor:
Yan Qiao, Bei Wang, Jiao-Jiao Yang, Yan-Feng Fan, Qian Guo, Zhan-Jun Dou, Ya-Qiong Huang, Ting-Ting Feng, Shu-Juan Wang, Dong-Dong An, Xiao-Ling Gao
Publikováno v:
Chinese Medical Journal, Vol 131, Iss 16, Pp 1898-1903 (2018)
Background: Obstructive sleep apnea syndrome (OSAS) is prevalent in obesity and is associated with many metabolic abnormalities. The relationship between OSAS and bone metabolism is still unclear. The aim of this study was to investigate the relation
Externí odkaz:
https://doaj.org/article/2b589d05c20c41c492832e6274440d94
Autor:
Xin Wei, Rui Guo, Xiao Wang, Jia-Jun Liang, Hao-Fei Yu, Cai-Feng Ding, Ting-Ting Feng, Li-Yan Zhang, Xia Liu, Xin-Yue Hu, Ying Zhou
Publikováno v:
Molecules, Vol 26, Iss 24, p 7457 (2021)
The well-known toxic medicine Gelsemium elegans is widely and historically used to treat bone fracture and skin ulcers by the folk people of China. Two new monoterpenoid indole alkaloids, gelselegandines D and E, together with the known analogue gele
Externí odkaz:
https://doaj.org/article/1cbb46952d37447b8b5bb0989dc5891b
Autor:
Yun-Feng Yan, Long Jiang, Ming-Duo Zhang, Xin-He Li, Mao-Xiao Nie, Ting-Ting Feng, Xin Zhao, Lu-Ya Wang, Quan-Ming Zhao
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0151259 (2016)
OBJECTIVE:In the era of bare metal stents (BMSs), alloys have been considered to be better materials for stent design than stainless steel. In the era of biodegradable polymer drug-eluting stents (BP-DESs), the safety and efficacy of BP-DESs with dif
Externí odkaz:
https://doaj.org/article/ea647c37248643f6bae22d1aeb1eb08d
Autor:
Quan-ming Zhao, Xin Zhao, Ting-ting Feng, Ming-duo Zhang, Xu-cui Zhuang, Xue-cheng Zhao, Li-qin Li, De-peng Li, Yu Liu
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e61140 (2013)
BACKGROUND: Detection of vulnerable plaques could be clinically significant in the prevention of cardiovascular events. We aimed to compare Fluorine-18 fluorodeoxyglucose ((18)F-FDG) uptake in vulnerable and stable plaques, and investigate the feasib
Externí odkaz:
https://doaj.org/article/1d5b37516fed4190b6c8b7e2ad84bd6b
Autor:
Zheng Hu, Xiao-Fen Pan, Fu-Qun Wu, Li-Yuan Ma, Da-Peng Liu, Ying Liu, Ting-Ting Feng, Fan-Yi Meng, Xiao-Li Liu, Qian-Li Jiang, Xiao-Qin Chen, Jing-Lei Liu, Ping Liu, Zhu Chen, Sai-Juan Chen, Guang-Biao Zhou
Publikováno v:
PLoS ONE, Vol 4, Iss 7, p e6257 (2009)
BACKGROUND: Resistance developed by leukemic cells, unsatisfactory efficacy on patients with chronic myeloid leukemia (CML) at accelerated and blastic phases, and potential cardiotoxity, have been limitations for imatinib mesylate (IM) in treating CM
Externí odkaz:
https://doaj.org/article/635934ee35264748a8f9bac393fc239e